TG Therapeutics | TGTX - Ebitda



金融业
股票价格
USD
资产
USD 1.64B
现金及等价物
USD 612.25M
销售成本
USD 41.19M
流动资产
USD 1.15B
流动负债
USD 268.49M
债务
USD 754.44M
EBIT
USD 21.67M
EBITDA
USD 26.9M
员工
338
EPS每股收益
USD 0.05
股本和储备
USD 604.08M
销售毛利
USD 199.14M
债务利息支出
USD 16.57M
贷款资金
USD 745.39M
市值
USD 7.98B
净收入
USD 7.78M
营业费用
USD 218.66M
营业利润
USD 21.67M
普通股股本
USD 153.08M
PE价格收益
19.64
税前利润
USD 10.23M
销售收入
USD 240.34M
销售和管理费用
USD 62.33M
股票
USD 147.97M
贸易债权人
USD 213.69M
应收帐款人
USD 401.57M


Ebitda 更改 日
AbbVie USD 3.69B 1.68B 2026-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 3.86B 1.28B 2026-03
Ardelyx USD -29.77M 35.79M 2026-03
Arrowhead Research USD -147.68M 40.33M 2026-06
Bayer EUR 2.14B 2.31B 2026-06
Biogen USD 649.7M 76.5M 2026-03
Corcept Therapeutics USD -49M 53.2M 2026-03
Curis USD -12.3M 231K 2023-09
Gilead Sciences USD 3.51B 489M 2026-03
J&J USD 8.27B 1.08B 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Novartis USD 6.48B 1.19B 2026-06
Novavax USD 19.36M 190.79M 2025-12
PTC Therapeutics USD 61.98M 132.97M 2026-03
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
TG Therapeutics USD 26.9M 1.21M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06